Showing results (211-220 of 238) with videos related to

Sort By:
Pageof 24
Current Topics in Medicinal Chemistry|February 3, 2004
Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticityE Sher, Y Chen, T J W Sharples, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 2, 2006
Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiatorsLisa M Broad, Ruud Zwart, Kathy H Pearson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2005
The association of physical activity and body mass index with the risk of large bowel polypsKristin Wallace, John A Baron, Margaret R Karagas, et al.
Breast Cancer Research and Treatment|January 1, 1982
Estrogen receptor status as a prognostic indicator for stage I breast cancer patientsJ P Crowe, C A Hubay, O H Pearson, et al.
European Journal of Pharmacology|April 8, 2003
Expression and functional characterisation of a human chimeric nicotinic receptor with alpha6beta4 propertiesNon M Evans, Suchira Bose, Giovanni Benedetti, et al.
Surgery|October 1, 1990
Short-term tamoxifen plus chemotherapy: superior results in node-positive breast cancerJ P Crowe, N H Gordon, R R Shenk, et al.
Breast Cancer Research and Treatment|January 1, 1983
Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: five-year resultsO H Pearson, C A Hubay, J S Marshall, et al.
Surgery|July 1, 1984
Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-upC A Hubay, N H Gordon, J P Crowe, et al.
Radiology|October 29, 2008
Lumbar spine: reliability of MR imaging findingsJohn A Carrino, Jon D Lurie, Anna N A Tosteson, et al.
European Journal of Pharmacology|October 2, 2002
PSAB-OFP, a selective alpha 7 nicotinic receptor agonist, is also a potent agonist of the 5-HT3 receptorLisa M Broad, Catherine Felthouse, Ruud Zwart, et al.
Pageof 24